Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening

This is the authors' abstract. We don't add key points for this paper.

In randomized clinical trials of cancer screening, incidence of late-stage cancer may be a suitable alternative end point to cancer-specific mortality for some cancer types, but is not suitable for others. These results have implications for clinical trials of multicancer screening tests.